An Intervention Based on Text Message (SMS) to Help Cancer Patients in Chemotherapy Treatment

Samanta Winck Madruga1 site in 1 country80 target enrollmentAugust 1, 2016

ConditionsCancer Side Effect

Overview

Phase: N/A
Intervention: Not specified
Conditions: Cancer
Sponsor: Samanta Winck Madruga
Enrollment: 80
Locations: 1
Primary Endpoint: Change from Chemotherapy Side Effects - QLQ-C30 EORTC questionnaire
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study evaluates the text message (SMS) with orientation to help the management of chemotherapy treatment.

Detailed Description

The investigators developed an app (called ChemotherApp) for Android that automatically sends text messages with homecare orientation to cancer patients in intervention group. The main features of this app are: to register information such as name, number of cellphone, gender, and chemotherapy schedule of the patient. Other feature is to register the orientation that will be sent to patients by text messages. Daily, the app send a registered orientation to each patient.

Registry

clinicaltrials.gov

Start Date

August 1, 2016

End Date

December 15, 2017

Last Updated

9 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Samanta Winck Madruga

Responsible Party

Sponsor Investigator

Principal Investigator

Samanta Winck Madruga

Hospital Escola

Federal University of Pelotas

Eligibility Criteria

Inclusion Criteria

•Cancer patients who will start chemotherapy treatment in Hospital Escola of Federal University of Pelotas.

Exclusion Criteria

•Illiterate patients; Patients who do not have their own cell phone

Outcomes

Primary Outcomes

Change from Chemotherapy Side Effects - QLQ-C30 EORTC questionnaire

Time Frame: Up to 4 month

To measure the side effects, the QLQ-C30 EORTC questionnaire is going to be used. This questionnaire aims to identify if the patient had nausea and vomit, diarrhea, pain, fever, constipation, diarrhea, gas, among other symptoms. It will be investigated if patients who will receive the text message will have less side effects than patients who will not receive text messages. The questionnaire will be applied to each patient in the study at the beginning of the second,third and fourth cycles of chemotherapy.